Mark Burns, PhD is T. C. Chang Professor of Engineering and Chair of the Chemical Engineering Department at the University of Michigan. He joined the University of Michigan in 1990 after teaching at the University of Massachusetts for 4 years. He obtained his MS and PhD in Chemical and Biochemical Engineering from the University of Pennsylvania, and his BS from the University of Notre Dame.
Dr. Burns’ group has published extensively on microfluidic technology. In the late ‘90s, his collaborative research team including David Burke (Human Genetics) constructed arguably the first microfabricated integrated DNA analysis device. Since that time, Dr. Burns has published on a variety of microfluidic analysis systems including a nanoliter viscometer with automated drop detection and an influenza device that is capable of detecting and subtyping strains of influenza. He has also published extensively on microfluidic pumping systems using, for example, temperature-controlled micropressure regulators and pneumatic logic gates. His current work centers on constructing inexpensive diagnostic systems for infectious diseases and developing cost effective sensors for a variety of applications including water quality assessment.
Dr. Burns has over 150 publications and patents, and he is a licensed professional engineer and a Fellow of the American Institute for Medical and Biological Engineering. He has won numerous awards including an Engineering Initiation Award from the National Science Foundation, and both a Research Excellence Award and a Teaching Excellence Award from the College of Engineering at the University of Michigan. He was the founding director of an Institutional Training Grant from the National Institutes of Health on Microfluidics in Biomedical Sciences, a program that involves 40 faculty from 14 different departments from across the University and is the only one of its kind in the country. He also was one of the co-founders of the innovative seed-funding program at U-M called MCubed and currently serves as the chair of the MCubed Executive Committee.
Dr. Eniola-Adefeso is the director of the Cell Adhesion and Drug Delivery lab at the University of Michigan. She graduated from the University of Maryland Baltimore County (UMBC) with a bachelor’s in Chemical and Biomolecular Engineering. She completed her masters (2000) and doctoral degree (2004) in Chemical and Biomolecular Engineering at the University of Pennsylvania. She was postdoctoral associate at Baylor College of Medicine in Houston, Texas in the Pediatrics/Leukocyte Biology Department.
Dr. Eniola-Adefeso’s research interests focus on the interactions between blood leukocytes and the endothelial cells lining the blood vessel lumen during inflammation response with the central goal of using acquired knowledge to facilitate the design of novel vascular-targeted drug delivery vehicles. Dr. Eniola-Adefeso’s lab currently focuses on two major research thrust: (1) elucidation the mechanism of the receptor-ligand interactions critical for the adhesion and migration of immune cells and (2) hemodynamics and hemorheology-driven design of sophisticated leukocyte mimetics particulate carriers for targeting therapeutics to diseased vasculature.
Since her arrival at Michigan, has received several honors and awards including the NSF CAREER Award, American Heart Association Innovator Award, and the American Heart Association Scientist Development Grant. Her research is currently funded by an R01 from the National Heart, Lung and Blood Institute, a grant from the National Science Foundation, and an industrial partnership with Banyan Biomarkers Inc.
Professor Nicholas A. Kotov is a Joseph and Florence V. Cejka Professor of Engineering at the University of Michigan. He graduated consecutively with a BS and PhD from Moscow State University where he was working on biomimetic interfaces. He later completed post-doctoral training at Syracuse University working on nanomaterials. Kotov has received multiple university, national, and international awards. He was elected as Fellow of the Royal Society of Chemistry in 2012. He serves as an Associate Editor for ACS Nano and as a member of Advisory Boards of several nanotechnology and materials journals.
Professor Kotov's research interests include multifunctional composites for biomedical implants, biosensors, and artificial organs. He is also developing nanoparticles for drug delivery and biomedical imaging. Some of the recent projects include structural design of nanomaterials to combat drug resistant bacteria and biofilms.
Dr. Lahann is a Professor of Chemical Engineering, Materials Science and Engineering and Biomedical Engineering at the University of Michigan. He also serves as the Director of the Biointerfaces Institute at the University of Michigan and the co-Director of the Institute for Functional Interfaces at the Karlrsruhe Institute of Technology, Germany. Dr. Lahann received a diploma degree and Ph.D. from the RWTH Aachen in Germany. He then completed a postdoctoral training in the research group of Prof. Robert S. Langer and the Massachusetts Institute of Technology. He joined the University of Michigan in 2003 as an Assistant Professor and was promoted to the rank of Associate Professor in 2008. Dr. Lahann is a co-author of more than 140 papers including papers in Science, Nature Materials, Nature Biotechnology, or PNAS and have contributed to more than 25 patents and patent applications.
Recent scientific advances in the Lahann lab on the molecular design of active nanostructures - such as the introduction of reactive coatings (Lahann et al., Angew. Chem. 2001), reversibly switching surfaces (Lahann et al., Science 2003), and anisotropic nanoparticles (Roh et al., Nature Materials 2005) - support the vision of smart interfaces that can act as templates in time-controlled surface interactions. His work has been highlighted in news articles in Science and Nature; has received substantial attention in the popular press/media including C&EN News, MRS Bulletin, Science News, National Public Radio, Nanoworld, and Newsweek; and has been selected as one of the research highlights in 2003 (C&EN News).
He has been selected by Technology Review as one of the top 100 young and the recipient of the 2007 Nanoscale Science and Engineering Award, a NSF-CAREER award, and both a single-PI and a team Idea award (2006 & 2011) from the US Department of Defense. Since 2011, he has been a fellow of the American Institute of Medical and Biological Engineering. The Lahann laboratory at the University of Michigan has contributed to more than 100 conference presentations and more than 140 publications in a wide spectrum of scientific journals with some of the highest impact factors in the field, including Science, Nature Materials, Nature Biotechnology, Nature Protocols, Nature Nanotechnology, Analytical Chemistry, Applied Physical Letters, Angewandte Chemie, Journal of the American Chemical Society (JACS), Advanced Materials, Biomaterials, or Proceedings of the National Academy of Sciences (PNAS) (see attached reference list for examples).
In the past nine years, Prof. Lahann has advised 24 graduate students from 4 different departments as well as 20 postdoctoral fellows. Dr. Lahann is an active member of several scientific societies including MRS, AICHE and ACS and serves on the editorial board of several journals including Macromolecular Rapid Communications and Advanced Healthcare Materials. He also has been the guest editor of two special issues in Macromolecular Rapid Communications and Advanced Materials and served as the editor of a book on Click Chemistry for Material Science and Biotechnology (2009, Wiley).